

Simon-Kucher’s MedTech practice focuses on devices, equipment, services, diagnostics, and digital health. Our experience and proven strategies enable our clients to sustainably increase their top line and generate profitable growth. While we count 40 out of the top 50 MedTech and Diagnostics companies among our clients, we also work with small- and mid-sized companies, including OEM suppliers and service companies for the healthcare industry.
The global healthcare environment is as complex as it has ever been. Decisions are being made jointly by clinical and economic stakeholders, who are requiring companies to demonstrate the true value, both clinical and health economic, of their products and services and reflect this in the price of the offer. This means companies must choose the right markets and segments, sell through effective channels, and convince the relevant stakeholders with a compelling value proposition that justifies their offer is worth the money. To achieve this, companies have to both identify the true value of their offer and have the right commercial and sales processes in place to extract this value from the market.
This is where Simon-Kucher excels. Our significant experience in Diagnostics and MedTech consulting empowers companies to achieve their revenue and profit targets. Our approach is one of working alongside our clients; we are results oriented and hands on, rolling up our sleeves to fully engage and understand the specific challenge. We analyze the products, markets, competitive landscape, and company sales and transaction data in order to gain a comprehensive view and make informed, intelligent decisions. We both develop the strategy and assist with implementation to ensure its longevity and results.
Our multidisciplinary team advises our clients on strategy, marketing, pricing, and sales topics. Our projects cover a variety of areas, including:
MedTech Experts
Featured Resources
视频
十月 05, 2020
Blog post
十月 05, 2020
Studies and Research
十月 05, 2020
Blog post
八月 24, 2020
COVID-19: How CDMOs Can Overcome Their 2 Key Commercial Challenges
Blog post
六月 04, 2020
10 Tactical Pricing and Contracting Measures to Maximize COVID-19 recovery in MedTech
Blog post
五月 05, 2020
Unlocking COVID-19 Diagnostic Testing Bottlenecks: Interview with Oguzhan Atay from BillionToOne
Blog post
四月 14, 2020
Transition in Time-Lapse: Revamping the Medtech Sales Model in Light of COVID-19
Studies and Research
二月 10, 2020
Blog post
一月 31, 2020
Blog post
十二月 20, 2019
Global Pricing Study 2019 - Focus Medtech: High Price Pressure, Limited Use of Digital Solutions
Blog post
八月 01, 2019
Blog post
六月 14, 2019
Facing the Digital Revolution: Life Sciences Companies Invest into Digital Health Solutions
Blog post
五月 24, 2017